Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
10.63
-1.88 (-15.03%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $19.98 million as of September 17, 2025.
Market Cap
19.98M
Enterprise Value
3.11M
1-Year Change
n/a
Ranking
Category
Stock Price
$10.63
Market Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $19.98M, an increase of 85.23%. That is a compound annual growth rate of 132.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 23.52M | 321.36% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 672.05B |
| Johnson & Johnson | 427.29B |
| AbbVie | 380.22B |
| UnitedHealth Group | 316.50B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 230.51B |